Digital Look

Welcome to Digital Look++,
you are not logged in

Advanced Search | Company A-Z | Feedback

4basebio (4BB)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,300.00p

Change Today:

0.000p
52 Week High: 1,820.00
52 Week Low: 545.00

Currency: UK Pounds
Shares Issued: 15.48m
Volume: 2

Market Cap: £201.21m
Beta: 0.18

4basebio Overview

4basebio UK Societas ("4bb" or "the Company") is a specialist life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for effective and safe delivery of these DNA based products to patients. Its main country of operation is the UK. It is the intention of the Company to become a market leader in the manufacture and supply of high purity, synthetic DNA for research, therapeutic and pharmacological use. The principal objective of 4bb is to validate and scale its DNA synthesis process with a view to manufacturing Good Manufacturing Practice ("GMP") grade DNA, suitable for use in gene therapies and DNA vaccines.

1 Day Chart

6 Month Chart

More 4basebio charts

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

	Latest	F'cast
Div Yield	0.0%	0.0%
Div Cover	n/a	n/a
Op Mrgn	-1591.3%	n/a
ROCE	n/a

	Latest	F'cast
P/E	n/a	n/a
PEG	n/a	n/a
Pr/Revenue	397.6	n/a
Pr/Book	n/a

	Latest	F'cast
Revenue	88.8%	n/a
PBT	n/a	n/a
EPS	n/a	n/a
DPS	n/a	n/a

4basebio Fundamentals

Year Ending	Revenue (£m)	Pre-tax (£m)	EPS	P/E	PEG	EPS Grth.	Div	Yield
31-Dec-19	0.20	(0.53)	(5.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-20	0.46	(0.72)	(8.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-21	0.34	(3.64)	(26.00)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-22	0.27	(5.93)	(0.42)p	n/a	n/a	n/a	n/a	0.0%
31-Dec-23	0.51	(8.35)	(0.62)p	n/a	n/a	n/a	n/a	0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

4basebio Company Announcements

4basebio Plc - Director's Dealing	19-Nov-2024	14:15	PR Newswire
4basebio Plc - Holding(s) in Company	15-Nov-2024	17:31	PR Newswire
4basebio Plc - Holding(s) in Company	15-Nov-2024	17:30	PR Newswire

More 4basebio company announcements

4basebio ShareCast News

4basebio losses widen as it progresses commercia...	27-Sep-2024	ShareCast
4basebio to provide synthetic DNA to tier-one ph...	10-Apr-2024	ShareCast
4basebio client gets approval to start trial in ...	21-Mar-2024	ShareCast

More 4basebio ShareCast news

Latest 4basebio Director Deals

Traded	Action	Notifier	Price	Amount	Value
15-Nov-24	Buy	Heikki Lanckriet	1,325.00p	46,500	£616,125.00
15-Nov-24	Sell	Heikki Lanckriet	1,325.00p	46,500	£616,125.00

More 4basebio director deals

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

4basebio Market Data

Currency	UK Pounds
Share Price	1,300.00p
Change Today	0.000p
% Change	0.00 %
52 Week High	1,820.00
52 Week Low	545.00
Volume	2
Shares Issued	15.48m
Market Cap	£201.21m
Beta	0.18